Our series, with 41 cases (28 related to nivolumab and 13 to pembrolizumab), confirms previous literature reports showing that hypophysitis can also occur while anti PD-114 and anti-PD-L1 are present18. The gene discussed is CD274; the disease is hypophysitis.